Andrew Gilroy Joins SecurEnds

Andrew brings over 10 years of start-up sales experience and 7 years of Governance & Compliance specific expertise to his new role at SecurEnds.  Andrew was most recently employed at IGA provider Saviynt as their Southeast Sales Director. While at Saviynt, Andrew helped grow the southeast’s customer base from 0 to more than 75 in just over 4 years.  Andrew has remarkable energy, passion, is a ‘Customer First’ sales person and dedicated team player.

Andrew Gilroy joins IGA startup as Director of Strategic Accounts.

As Director of Strategic Accounts, Andrew’s focus will be sales growth for SecurEnds’ largest prospects and customers. In this role, Andrew will work closely with executive leadership and colleagues to develop sales strategy and execution nationwide.

Personally, Andrew is a U.S. ARMY veteran and proud graduate of Penn State University. He is a husband and father of an 18-year-old son, who is bound for UT Austin this fall. He loves spending time traveling with his family, gourmet cooking, fishing, and boating in the Bahamas any chance he gets. Andrew and his family reside in Parkland, FL, a suburb of Fort Lauderdale, since moving in 1997.

Connect with Andrew via LinkedIn: https://www.linkedin.com/in/agilroy/

SecurEnds: The Leading Identity Governance Platform

SecurEnds provides a cloud born Identity Governance solution that allows organizations to secure identities, protect against potential breaches, and meet security compliance. Using SecurEnds’ platform, organizations can securely and effectively complete Access Certifications, Access Requests, Identity Risk & Analytics and Cloud Identity & Access Management. Many satisfied customers rely on SecurEnds to meet access controls for SOX, HIPAA, PCI, HITRUST, and many other compliance audits.

Media Inquiries: Bethany Jones  |   334-590-7602   |   Bethany.Jones@SecurEnds.com

Total
0
Shares
Leave a Reply
Related Posts
Read More

Expression Therapeutics Announces Bill Swaney as VP of Manufacturing and the Construction of Cell and Gene Therapy Manufacturing

Expression Therapeutics has announced the appointment of Bill Swaney as the Vice President of Manufacturing. He comes to Expression Therapeutics from the Cincinnati Children's Hospital Medical Center where he was the Director of the Vector Production Facility & Viral Vector Core. Mr. Swaney is an internationally recognized expert in GMP cell and gene therapy manufacturing and has conducted over 70 GMP production runs for academic and commercial clients.